JP Patent

JP6903923B2 — ヘテロアリールで置換されたフェニルテトラヒドロイソキノリン化合物を有効成分として含有する医薬

Assigned to Taisho Pharmaceutical Co Ltd · Expires 2021-07-14 · 5y expired

What this patent protects

Patent listed against tenapanor-hydrochloride.

Drugs covered by this patent

tenapanor-hydrochloride (TENAPANOR HYDROCHLORIDE)

Patent Metadata

Patent number: JP6903923B2
Jurisdiction: JP
Classification: —
Expires: 2021-07-14
Drug substance claim: No
Drug product claim: No
Assignee: Taisho Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.